CD274 and diabetes mellitus: Given the clinical relevance of PD-L1 in immune checkpoint inhibition and the potential impact of metformin on the tumor microenvironment, this study aims to contribute to a better understanding of the interplay between diabetes treatment and immune modulation in OSCC.